References
Honnorat J, Cartalat–Carel S (2004) Advances in paraneoplastic neurological syndromes. Curr Opin Oncol 16:614–620
Berger JR, Mehari E (1999) Paraneoplastic opsoclonus–myoclonus secondary to malignant melanoma. J Neurooncol 41:43–45
Liu GT, Volpe NJ, Galetta SL (2001) Eye movement disorders: Nystagmus and nystagmoid eye movements. In: Saunders WB (ed) Neuro–ophthalmology. Diagnosis and Management. Company, Philadelphia, pp 627–650
Rees JH (2004) Paraneoplastic syndromes: When to suspect, how to confirm, and how to manage. J Neurol Neurosurg Psychiatry 75(2):ii43–50
Bataller L, Graus F, Saiz A, Vilchez JJ (2001) Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus– myoclonus. Brain 124:437–443
Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler C, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–1140
Anderson NE, Budde–Steffen C, Rosenblum MK, Graus F, Ford D, Synek BJ, Posner JB (1988) Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: A distinct paraneoplastic syndrome. Medicine 67:100–109
Author information
Authors and Affiliations
Corresponding author
Additional information
Electronic supplementary material is available if you access the Local HTML full text version of the article at http://dx.doi.org/10.1007/s00415-006-0026-1
Rights and permissions
About this article
Cite this article
Jung, KY., Youn, J. & Chung, CS. Opsoclonus–myoclonus syndrome in an adult with malignant melanoma. J Neurol 253, 942–943 (2006). https://doi.org/10.1007/s00415-006-0026-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-006-0026-1